Robeco Schweiz’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.57M Buy
29,742
+13,213
+80% +$1.17M 0.05% 122
2026
Q2
$1.5M Buy
+16,529
New +$1.38M 0.02% 123
2018
Q2
– Sell
-936
Closed -$44K – 180
2018
Q1
$44K Sell
936
-657
-41% -$28.5K ﹤0.01% 174
2017
Q4
$61K Buy
+1,593
New +$58.5K ﹤0.01% 172

Other funds holding EW

Robeco Schweiz's EW Position: Q3 2026 in Review

Robeco Schweiz increased its Edwards Lifesciences (EW) stake by 80% in Q3 2026, buying an estimated $1.17M and bringing the position to 29,742 shares worth $2.57M. The position accounts for 0.05% of the portfolio, ranked #122.

Robeco Schweiz first reported a position in EW in Q4 2017 and has held it in 4 quarters since. 326 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Robeco Schweiz held 29,742 shares of Edwards Lifesciences worth $2.57M as of Q3 2026.
  • Robeco Schweiz bought 13,213 Edwards Lifesciences shares in Q3 2026, an estimated $1.17M.
  • Edwards Lifesciences made up 0.05% of Robeco Schweiz's portfolio in Q3 2026, its #122 holding.
  • Robeco Schweiz first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 4 quarters since.
  • 326 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Robeco Schweiz's 13F filing for Q3 2026, filed 23 Oct 2026.